BIO-key International (NASDAQ:BKYI) Share Price Crosses Below 200-Day Moving Average – Time to Sell?

Shares of BIO-key International Inc. (NASDAQ:BKYI) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $5.79 and traded as low as $3.71. BIO-key International shares last traded at $3.80, with a volume of 4,290 shares changing hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, BIO-key International presently has an average rating of “Sell”.

BIO-key International Stock Performance

The company has a 50 day simple moving average of $4.85 and a 200 day simple moving average of $5.77. The company has a current ratio of 1.26, a quick ratio of 1.13 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $4.12 million, a PE ratio of -0.54 and a beta of 0.44.

BIO-key International (NASDAQ:BKYI) last posted its quarterly earnings data on Tuesday, March 31st. The technology company reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.70) by $0.51. The company had revenue of $1.24 million during the quarter, compared to analysts’ expectations of $2.20 million. BIO-key International had a negative return on equity of 67.43% and a negative net margin of 75.32%.

Hedge Funds Weigh In On BIO-key International

A hedge fund recently raised its position in BIO-key International stock. Geode Capital Management LLC grew its position in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the quarter. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 as of its most recent filing with the SEC. 26.51% of the stock is owned by hedge funds and other institutional investors.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.